Holen Sie sich die Stockscreener-App
4.93
3.90%
-0.20
Schlusskurs vom Vortag:
$5.13
Offen:
$5.01
24-Stunden-Volumen:
44,056
Relative Volume:
0.18
Marktkapitalisierung:
$58.11M
Einnahmen:
$52.29M
Nettoeinkommen (Verlust:
$-73.52M
KGV:
-7.4697
EPS:
-0.66
Netto-Cashflow:
$-100.45M
1W Leistung:
+0.41%
1M Leistung:
-3.90%
6M Leistung:
-3.14%
1J Leistung:
-46.00%
1-Tages-Spanne:
$4.90
$5.1124
1-Wochen-Bereich:
$4.70
$5.16
52-Wochen-Spanne:
$3.61
$9.8131
Precision Biosciences Inc Stock (DTIL) Company Profile
Firmenname
Precision Biosciences Inc
Sektor
Branche
Telefon
919-314-5512
Adresse
302 EAST PETTIGREW STREET, DURHAM, NC
Vergleichen Sie DTIL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
4.93 | 60.47M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2024-04-30 | Eingeleitet | Guggenheim | Buy |
| 2022-06-17 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-06-09 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2020-07-27 | Fortgesetzt | BTIG Research | Buy |
| 2020-04-03 | Herabstufung | Goldman | Buy → Neutral |
| 2020-03-05 | Eingeleitet | Stifel | Buy |
| 2020-02-25 | Eingeleitet | William Blair | Outperform |
| 2019-08-09 | Eingeleitet | BTIG Research | Buy |
| 2019-07-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-04-22 | Eingeleitet | Barclays | Overweight |
| 2019-04-22 | Eingeleitet | Goldman | Buy |
| 2019-04-22 | Eingeleitet | JP Morgan | Overweight |
| 2019-04-22 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Precision Biosciences Inc Aktie (DTIL) Neueste Nachrichten
Brown Melinda buys $6846 in Precision BioSciences (DTIL) By Investing.com - Investing.com Nigeria
Brown Melinda buys $6846 in Precision BioSciences (DTIL) - Investing.com India
Insider Buying: Melinda Brown Acquires Shares in Precision BioSc - GuruFocus
Risk Recap: How does Precision BioSciences Inc correlate with Nasdaq2025 Technical Overview & Precise Swing Trade Alerts - خودرو بانک
Layoff Tracker: Arvinas Downsizes by 15% After Punting Pfizer-Partnered Asset - BioSpace
Candlestick signals on Precision BioSciences Inc. stock today2025 Year in Review & Growth Oriented Trade Recommendations - newser.com
Published on: 2025-09-18 07:24:27 - newser.com
Precision BioSciences (DTIL) Reports Q4 Loss, Misses Revenue Estimates - MSN
AI Stocks: What is the long term forecast for Precision BioSciences Inc. stockWeekly Profit Report & Long-Term Capital Growth Strategies - خودرو بانک
ARCUS Gene Editor Shows Promise Against Hepatitis B - CRISPR Medicine News
Surprises Report: Is Precision BioSciences Inc stock trending bullish2025 Momentum Check & Target Return Focused Picks - خودرو بانک
Insider Buy: Whats the outlook for Precision BioSciences Incs sectorJuly 2025 Pullbacks & High Conviction Investment Ideas - خودرو بانک
Is Precision BioSciences Inc likely to announce a buyback2025 Market Trends & Reliable Intraday Trade Alerts - خودرو بانک
Published on: 2025-09-16 12:16:08 - newser.com
Is Precision BioSciences Inc. building a consolidation baseTrade Analysis Summary & Free Fast Gain Swing Trade Alerts - newser.com
Nasdaq Moves: What is the long term forecast for Precision BioSciences Inc stockStop Loss & Weekly Market Pulse Alerts - خودرو بانک
Precision BioSciences Presents Data from the Phase 1 ELIMINATE-B Trial of PBGENE-HBV at the 6th International Coalition to Eliminate HBV Cure Symposium - BioSpace
Transcript : Precision BioSciences, Inc. Presents at H.C. Wainwright 27th Annual Global Investment Conference, Sep-09-2025 10 - MarketScreener
Sectors Review: Is Precision BioSciences Inc a speculative investmentJuly 2025 Snapshot & Real-Time Volume Trigger Notifications - خودرو بانک
What momentum shifts mean for Precision BioSciences Inc.Take Profit & Weekly High Potential Alerts - newser.com
Stock Analysis: Does BNTX offer margin of safetyPortfolio Update Summary & Stock Portfolio Risk Management - خودرو بانک
Smart tools for monitoring Precision BioSciences Inc.’s price actionMarket Sentiment Review & Technical Entry and Exit Alerts - newser.com
Reversal indicators forming on Precision BioSciences Inc. stockPortfolio Gains Summary & Safe Entry Momentum Stock Tips - newser.com
How to integrate Precision BioSciences Inc. into portfolio analysis tools2025 Valuation Update & Stepwise Entry and Exit Trade Signals - newser.com
When is the best time to exit Precision BioSciences Inc.M&A Rumor & AI Based Trade Execution Alerts - newser.com
Precision BioSciences Inc. stock volume spike explainedWatch List & Safe Entry Point Identification - newser.com
What MACD signals say about Precision BioSciences Inc.July 2025 Trends & Community Verified Trade Signals - newser.com
Precision BioSciences presents data from hepatitis B gene editing trial By Investing.com - Investing.com Australia
Can Precision BioSciences Inc. hit a new high this monthGlobal Markets & Free High Return Stock Watch Alerts - Newser
Is Precision BioSciences Inc. stock poised for growthWeekly Gains Report & Reliable Volume Spike Trade Alerts - Newser
Precision BioSciences Presents Data from the Phase 1 ELIMINATE-B Trial - Contract Pharma
Will Precision BioSciences Inc. bounce back from current supportTreasury Yields & AI Powered Market Entry Strategies - Newser
Custom strategy builders for tracking Precision BioSciences Inc.July 2025 PostEarnings & High Return Trade Opportunity Guides - Newser
Precision BioSciences Presents Data from the Phase 1 ELIMINATE-B Trial of PBGENE-HBV at the 6th Inte - PharmiWeb.com
Precision BioSciences presents phase 1 PBGENE-HBV trial data at HBV Cure Symposium; targets chronic hepatitis B - MarketScreener
Precision BioSciences presents data from hepatitis B gene editing trial - Investing.com
Statistical indicators supporting Precision BioSciences Inc.’s strengthJuly 2025 Chart Watch & Advanced Technical Analysis Signals - Newser
Risk adjusted return profile for Precision BioSciences Inc. analyzedJuly 2025 Decliners & Short-Term Trading Opportunity Alerts - Newser
Will Precision BioSciences Inc. price bounce be sustainableTrade Entry Report & Reliable Price Breakout Signals - Newser
Top chart patterns to watch in Precision BioSciences Inc.July 2025 Highlights & Reliable Breakout Forecasts - Newser
Will Precision BioSciences Inc. continue its uptrendEarnings Overview Report & Daily Profit Maximizing Trade Tips - Newser
What MACD and RSI say about Precision BioSciences Inc.2025 Biggest Moves & Real-Time Sentiment Analysis - Newser
Comparing Precision BioSciences Inc. in custom built stock radarsMarket Growth Review & Free AI Powered Buy and Sell Recommendations - Newser
Finanzdaten der Precision Biosciences Inc-Aktie (DTIL)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):